{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:55:34Z","timestamp":1789707334909,"version":"4.0.1"},"reference-count":21,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the safety and efficacy of prophylactic Ripasudil in maintaining corneal endothelial function and preventing corneal failure in patients with late-stage Fuchs corneal dystrophy (FCD) undergoing femtolaser-assisted cataract surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Major findings<\/jats:title>\n                    <jats:p>\n                      This prospective, randomized, open-label, controlled interventional study included 41 eyes from 27 patients, 27 eyes treated with Ripasudil and 14 with hyaluronic acid as a control. Treatment was administered from 1 month before cataract surgery through 2 months postoperatively. Primary outcomes included best-corrected visual acuity (BCVA), central corneal thickness (CCT), and endothelial cell density and morphology, assessed at baseline, 3 months, and 9 months after surgery. Statistical analysis was performed using the unpaired t-test with Welch's correction and the Wilcoxon matched-pairs test, with a significance threshold of\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05. The Ripasudil group showed a significant improvement in BCVA, from0.3\u2009\u00b1\u20090.3 to 0.2\u2009\u00b1\u20090.2 LogMAR (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.01), along with stable CCT (556.3\u2009\u00b1\u200976.4\u2005\u03bcm at baseline vs. 563.3\u2009\u00b1\u200972.2\u2005\u03bcm at post-operative month 3,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.39). In contrast, the control group demonstrated no significant improvement in BCVA (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.13) and a significant increase in CCT (from 591.9\u2009\u00b1\u200959.3\u2005\u03bcm to 658.4\u2009\u00b1\u200974.6\u2005\u03bcm,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Endothelial cell density, polymegathism, and pleomorphism remained stable in both groups. At 9 months, Ripasudil-treated eyes continued to show stability in both BCVA and CCT, with no adverse events reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ripasudil demonstrated a protective effect on the corneal endothelium during cataract surgery in late-stage FCD patients, with better visual outcomes and reduced postoperative corneal edema.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11206721251351154","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T06:06:42Z","timestamp":1750140402000},"page":"2041-2049","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rock-Inhibitors eyedrops preventing cataract surgery induced corneal failure in Fuchs corneal dystrophy"],"prefix":"10.1177","volume":"35","author":[{"given":"Daniele","family":"Gaudenzi","sequence":"first","affiliation":[{"name":"Ophthalmology Campus Bio-Medico University, Rome, Italy"},{"name":"Campus Bio-Medico University Hospital Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De Gregorio","sequence":"additional","affiliation":[{"name":"Ophthalmology Campus Bio-Medico University, Rome, Italy"},{"name":"Campus Bio-Medico University Hospital Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cutrupi","sequence":"additional","affiliation":[{"name":"Ophthalmology Campus Bio-Medico University, Rome, Italy"},{"name":"Campus Bio-Medico University Hospital Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Branda","sequence":"additional","affiliation":[{"name":"Unit of Medical Statistics and Molecular Epidemiology, Campus Bio-Medico University, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Coassin","sequence":"additional","affiliation":[{"name":"Ophthalmology Campus Bio-Medico University, Rome, Italy"},{"name":"Campus Bio-Medico University Hospital Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9051-7928","authenticated-orcid":false,"given":"Antonio","family":"Di Zazzo","sequence":"additional","affiliation":[{"name":"Ophthalmology Campus Bio-Medico University, Rome, Italy"},{"name":"Campus Bio-Medico University Hospital Foundation"},{"name":"Campus Bio-Medico University Hospital Foundation"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13041"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.07.015"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2018.03.023"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2021.101245"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666161205110027"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2634"},{"key":"e_1_3_2_8_2","first-page":"1626","article-title":"The efficacy of a rho kinase inhibitor in the treatment of fuchs endothelial corneal dystrophy","volume":"118","author":"Shima N","year":"2011","unstructured":"Shima N, Kimoto K, Yamaguchi M, et al. The efficacy of a rho kinase inhibitor in the treatment of fuchs endothelial corneal dystrophy. Ophthalmology 2011; 118: 1626\u20131630.","journal-title":"Ophthalmology"},{"key":"e_1_3_2_9_2","first-page":"7405","article-title":"Rho-associated kinase inhibitor eye drop (Ripasudil) transiently alters the morphology of corneal endothelial cells","volume":"55","author":"Koizumi N","year":"2014","unstructured":"Koizumi N, Okumura N, Ueno M, et al. Rho-associated kinase inhibitor eye drop (Ripasudil) transiently alters the morphology of corneal endothelial cells. Invest Ophthalmol Vis Sci 2014; 55: 7405\u20137415.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_10_2","first-page":"1029","article-title":"Modulation of aqueous humor outflow facility by the rho kinase-specific inhibitor Y-27632","volume":"42","author":"Rao PV","year":"2001","unstructured":"Rao PV, Deng P-F, Kumar J, et al. Modulation of aqueous humor outflow facility by the rho kinase-specific inhibitor Y-27632. Invest Ophthalmol Vis Sci 2001; 42: 1029\u20131037.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.022"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2020.12.006"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002642"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000748"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Karri R Chong EW. ROCK Inhibitors in ophthalmology: a critical review of the existing clinical evidence. July 2023; 51: 472\u2013483. https:\/\/doi.org\/10.1111\/ceo.14224","DOI":"10.1111\/ceo.14224"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062095"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712770"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000240"},{"key":"e_1_3_2_19_2","first-page":"355","article-title":"The impact of preoperative administration of rho kinase inhibitor on endothelial cell density in cataract surgery patients","volume":"60","author":"Ueno M","year":"2016","unstructured":"Ueno M, Asada K, Toda M, et al. The impact of preoperative administration of rho kinase inhibitor on endothelial cell density in cataract surgery patients. Jpn J Ophthalmol 2016; 60: 355\u2013360.","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_3_2_20_2","first-page":"20","article-title":"Functional and morphological restoration of corneal endothelial cells using Rho kinase inhibitor Y-27632","volume":"99","author":"Maruyama K","year":"2012","unstructured":"Maruyama K, Yokoo S, Komizu N, et al. Functional and morphological restoration of corneal endothelial cells using Rho kinase inhibitor Y-27632. Exp Eye Res 2012; 99: 20\u201328.","journal-title":"Exp Eye Res"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001883"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.08.006"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721251351154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721251351154","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721251351154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:54:08Z","timestamp":1784019248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721251351154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/11206721251351154"],"URL":"https:\/\/doi.org\/10.1177\/11206721251351154","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}